Han et al. (13) found that the lncRNA MEG3 methylation level increased successively in the serum of healthy subjects, patients with low-stage cervical cancer, high-stage cervical cancer, and cervical cancer with lymph node metastasis, indicating that MEG3 methylation might be a marker of disease progression in cervical cancer. The gene discussed is MEG3; the disease is cervical cancer.